# TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma

> **NCT01349075** · — · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University** · enrollment: 474 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **RADIATION:** TheraSphere

## Key facts

- **NCT ID:** NCT01349075
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2021-03-15
- **Final completion:** 2021-03-15
- **Target enrollment:** 474 (ACTUAL)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01349075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01349075, "TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01349075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*